Article
SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop.
Cell death & disease - 12 Feb 2020
An Yifei, Wang Bo, Wang Xin, Dong Guoying, Jia Jihui, Yang Qing
Abstract excerpt
Chemotherapy is the standard care for patients with gastric cancer (GC); however, resistance to existing drugs has limited its success. The persistence of cancer stem cells (CSCs) is considered to be responsible for treatment failure. In this study, we demonstrated that SIRT1 expression was significantly downregulated in GC tissues, and that a low SIRT1 expression level indicated a poor prognosis in GC patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
